Evidence map›Paper›PMID 24722418›Full record

ArticlePloS one2014

Melanoma transition is frequently accompanied by a loss of cytoglobin expression in melanocytes: a novel expression site of cytoglobin.

Yoshihiko Fujita, Satoshi Koinuma, Marco A De Velasco, Jan Bolz, Yosuke Togashi, Masato Terashima, Hidetoshi Hayashi, Takuya Matsuo, Kazuto Nishio

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Cytoglobin has potent superoxide dismutase function.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Discovery of cytoglobin and its roles in physiology and pathology of hepatic stellate cells.Proceedings of the Japan Academy. Series B, Physical and biological sciences · 2016
    Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yoshihiko FujitaDepartment of Genome Biology, Faculty of Medicine, Kinki University, Osaka-Sayama, Osaka, Japan.
Satoshi KoinumaDepartment of Anatomy and Neurobiology, Faculty of Medicine, Kinki University, Osaka-Sayama, Osaka, Japan.
Marco A De VelascoDepartment of Genome Biology, Faculty of Medicine, Kinki University, Osaka-Sayama, Osaka, Japan.
Jan BolzDepartment of Genome Biology, Faculty of Medicine, Kinki University, Osaka-Sayama, Osaka, Japan.
Yosuke TogashiDepartment of Genome Biology, Faculty of Medicine, Kinki University, Osaka-Sayama, Osaka, Japan.
Masato TerashimaDepartment of Genome Biology, Faculty of Medicine, Kinki University, Osaka-Sayama, Osaka, Japan.
Hidetoshi HayashiDepartment of Genome Biology, Faculty of Medicine, Kinki University, Osaka-Sayama, Osaka, Japan.
Takuya MatsuoDepartment of Anatomy and Neurobiology, Faculty of Medicine, Kinki University, Osaka-Sayama, Osaka, Japan.
Kazuto NishioDepartment of Genome Biology, Faculty of Medicine, Kinki University, Osaka-Sayama, Osaka, Japan.
Kindai University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The tissue distribution and function of hemoglobin or myoglobin are well known; however, a newly found cytoglobin (CYGB), which also belongs to the globin family, remains to be characterized. To assess its expression in human malignancies, we sought to screen a number of cell lines originated from many tissues using northern blotting and real time PCR techniques. Unexpectedly, we found that several, but not all, melanoma cell lines expressed CYGB mRNA and protein at much higher levels than cells of other origins. Melanocytes, the primary origin of melanoma, also expressed CYGB at a high level. To verify these observations, immunostaining and immunoblotting using anti-CYGB antibody were also performed. Bisulfite-modified genomic sequencing revealed that several melanoma cell lines that abrogated CYGB expression were found to be epigenetically regulated by hypermethylation in the promoter region of CYGB gene. The RNA interference-mediated knockdown of the CYGB transcript in CYGB expression-positive melanoma cell lines resulted in increased proliferation in vitro and in vivo. Flow cytometric analysis using 2'-, 7'-dichlorofluorescein diacetate (DCFH-DA), an indicator of reactive oxygen species (ROS), revealed that the cellular ROS level may be involved in the proliferative effect of CYGB. Thus, CYGB appears to play a tumor suppressive role as a ROS regulator, and its epigenetic silencing, as observed in CYGB expression-negative melanoma cell lines, might function as an alternative pathway in the melanocyte-to-melanoma transition.

Indexed as

Cell Line, TumorCell Transformation, NeoplasticCytoglobinDNA MethylationEpigenesis, GeneticGlobinsHumansMelanocytesMelanomaSkin NeoplasmsCYGB protein, humanCytoglobinGlobins

Identifiers

PMID24722418
PMCPMC3983271
OpenAlexW2048350195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.